carbamazepine has been researched along with Hyperlipemia in 5 studies
Carbamazepine: A dibenzazepine that acts as a sodium channel blocker. It is used as an anticonvulsant for the treatment of grand mal and psychomotor or focal SEIZURES. It may also be used in the management of BIPOLAR DISORDER, and has analgesic properties.
carbamazepine : A dibenzoazepine that is 5H-dibenzo[b,f]azepine carrying a carbamoyl substituent at the azepine nitrogen, used as an anticonvulsant.
| Excerpt | Relevance | Reference |
|---|---|---|
| " Similar pharmacokinetic changes were observed in HL rats after oral administration of CBZ." | 1.38 | Effects of poloxamer 407-induced hyperlipidemia on the pharmacokinetics of carbamazepine and its 10,11-epoxide metabolite in rats: Impact of decreased expression of both CYP3A1/2 and microsomal epoxide hydrolase. ( Kang, HE; Kim, SG; Kim, YW; Lee, I; Lee, MG; Lee, YS, 2012) |
| "Oxcarbazepine has been reported to be a preferable antiepileptic drug, when compared to carbamazepine with respect to its effects on lipid metabolism, especially cholesterol, high-density lipoproteins, and low-density lipoproteins." | 1.31 | Oxcarbazepine versus carbamazepine treatment and induction of serum lipid abnormalities. ( Papacostas, S, 2000) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (40.00) | 18.2507 |
| 2000's | 2 (40.00) | 29.6817 |
| 2010's | 1 (20.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Castro-Gago, M | 1 |
| Eirís-Puñal, J | 1 |
| Lee, YS | 1 |
| Kim, YW | 1 |
| Kim, SG | 1 |
| Lee, I | 1 |
| Lee, MG | 1 |
| Kang, HE | 1 |
| Verrotti, A | 1 |
| Domizio, S | 1 |
| Angelozzi, B | 1 |
| Sabatino, G | 1 |
| Morgese, G | 1 |
| Chiarelli, F | 1 |
| Pita-Calandre, E | 1 |
| Rodríguez-López, CM | 1 |
| Cano, MD | 1 |
| Peña-Bernal, M | 1 |
| Papacostas, S | 1 |
5 other studies available for carbamazepine and Hyperlipemia
| Article | Year |
|---|---|
Correspondence on "Lipid profile, apolipoproteins A and B in children with epilepsy''.
Topics: Adolescent; Anticonvulsants; Apolipoprotein A-I; Apolipoproteins; Apolipoproteins B; Atherosclerosis | 2009 |
Effects of poloxamer 407-induced hyperlipidemia on the pharmacokinetics of carbamazepine and its 10,11-epoxide metabolite in rats: Impact of decreased expression of both CYP3A1/2 and microsomal epoxide hydrolase.
Topics: Analgesics, Non-Narcotic; Animals; Arabidopsis Proteins; Area Under Curve; Carbamazepine; Chromatogr | 2012 |
Changes in serum lipids and lipoproteins in epileptic children treated with anticonvulsants.
Topics: Adolescent; Anticonvulsants; Carbamazepine; Child; Epilepsy; Female; Humans; Hyperlipidemias; Lipids | 1997 |
[Serum lipids. lipoproteins, and apolipoproteins in adult epileptics treated with carbamazepine, valproic acid, or phenytoin].
Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Apolipoproteins; Carbamazepine; Cholesterol; Choles | 1998 |
Oxcarbazepine versus carbamazepine treatment and induction of serum lipid abnormalities.
Topics: Anticonvulsants; Carbamazepine; Child, Preschool; Cholesterol, LDL; Dose-Response Relationship, Drug | 2000 |